NRX Pharmaceuticals, Inc. (NRXP) › Operating Cash FlowNRX Pharmaceuticals, Inc. (NRXP) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$473.2K2019: -$792.7K2020: -$2.27M2021: -$37.70M2022: -$39.76M2023: -$21.66M2024: -$10.64M2025: -$14.11M-$14.11M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$14.11M-32.7%2024-$10.64M+50.9%2023-$21.66M+45.5%2022-$39.76M-5.4%2021-$37.70M-1564.6%2020-$2.27M-185.7%2019-$792.7K-67.5%2018-$473.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share